Eli Lilly and Company

Eli Lilly and Company is exploring how blockchain technology can revolutionize pharmaceutical supply chains, enhance data security and integrity for clinical trials, and improve patient data management. By leveraging distributed ledger technology, we aim to increase transparency, combat counterfeit drugs, and streamline operations within the healthcare ecosystem.